This session describes the National Health Council and opportunities for Medical Affairs professionals to get involved.
Patient Advisors and Diversity Experts share their perspectives on diverse representation in clinical trials and key barriers to research access, and explore solutions to address these critical issues.
Join this session to understand aligned HCP and patient education activities from the perspective of the current landscape, Medical Affairs support for aligned medical education and risk mitigation ensuring transparency, fairness and lawfulness.
This MAPS podcast describes publication plain-language summaries and how patients find them useful.
Join this session to understand how an effective digital tele-mentoring program builds local capacity in rural and underserved areas by empowering healthcare professionals to treat complex diseases that have historically only been treated by specialists.
This MAPS podcast explores the value and challenges of publication plain-language (PLS) summaries in the pharmaceutical industry.
Understand the numerous ways in which partnership with patients can impact the development and commercialization of medicines; the current “patient centric” landscape in pharmaceutical drug development; recent findings related to the value of patient-centric trial design, and innovative approaches to engaging with patients across the study continuum.
Analysis of RWD leads to clinical evidence known as real world evidence (RWE) regarding the usage and risks and benefits of a therapy. Under the right conditions, RWD and the RWE that follows may be used to support regulatory decisions and contribute to the knowledge of a drug or therapy. RWE may help to support improved decision-making about health and health care.